< Back to Schedule

Parallel Session: Hepatitis B: Therapeutics (Established)

Saturday, November 14
 
9:00 am
 - 
10:30 am

Speakers

No items found.

About the Session

Watch this live session to see the top research in Hepatitis B Therapeutics. Content will only be aired on this date, at this time. Don't miss it!

  • Randomized Trial of 192 Weeks of Tenofovir With or Without Peginterferon Alpha for the First 24 Weeks Followed by Protocolized Withdrawal in Adults with Chronic Hepatitis
    Presenting Author Norah Terrault
  • Tenofovir Alafenamide Fumarate Therapy for the Prevention of Hepatitis B Vertical Transmission in Highly Viremic Mothers with Chronic Hepatitis B
    Presenting Author Calvin Pan
  • Longitudianal Real World Study On Estimated Glomerular Filtration Rate (EGFR) Changes in Entecavir (ETV) Versus Tonfovir Disoproxil Fumarate (TDF)-Treated Chronic Hepatitis B Patients: A Real-B Study
    Presenting Author Lung Yi Mak
  • Long Term Nucleos(t)ide Analogue Therapy Reduced the Extent of HBV DNA Integration in Chronic Hepatitis B Patients                                                       Presenting Author Ning Chow
  • HBsAg Loss is Higher Among Caucasions Compared to Asicans after Stopping Nucleos(t)ide Analogue Therapy: Results from a Large, Global, Multi-Ethnic Cohort of Patients with Chronic Hepatitis B (Retract-B Study)
    Presenting Author Grishma Hirode
  • Real World Single Center Experience on the Efficacy of Stopping Long Term Nucleos(t)ide Analog Therapy in Patients with Chronic Hepatitis B                       Presenting Author Hassan Azhari